Literature DB >> 34545996

Encapsulation and differentiation of adipose-derived mesenchymal stem cells in a biomimetic purine cross-linked chitosan sponge.

Antoine Karoichan1,2, Timothée Baudequin3, Hadil Al-Jallad1,2,4, Maryam Tabrizian1,3.   

Abstract

Mesenchymal stem cells derived from adipose tissue have become a widely investigated cell source to use in tissue engineering applications. However, an optimal delivery scaffold for these cells is still needed. A rapidly gelling, injectable chitosan sponge was proposed in this study as a potential candidate for a suitable delivery scaffold. The results demonstrated the ability to encapsulate the stem cells at a 97.6% encapsulation efficiency and that the cells maintain their viability within the sponge. With the potential of using this scaffold for bone tissue engineering, ALP activity assay and fluorescent imaging for osteocalcin proved the ability to differentiate the encapsulated cells into the osteogenic lineage. Furthermore, co-encapsulation of pyrophosphatase within the sponge was investigated as a method to overcome the inhibitory effects that the sponge degradation by-products have on mineralization. Alizarin Red S staining demonstrated the beneficial effects of adding pyrophosphatase, where a significant increase in mineralization levels was achieved.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  adipose-derived mesenchymal stem cells; bone tissue engineering; chitosan scaffold; injectable hydrogel; stem cell differentiation; stem cell encapsulation

Mesh:

Substances:

Year:  2021        PMID: 34545996     DOI: 10.1002/jbm.a.37311

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  1 in total

1.  Enhancing metabolic activity and differentiation potential in adipose mesenchymal stem cells via high-resolution surface-acoustic-wave contactless patterning.

Authors:  Karina Martinez Villegas; Reza Rasouli; Maryam Tabrizian
Journal:  Microsyst Nanoeng       Date:  2022-07-12       Impact factor: 8.006

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.